Torrent Pharma Stock Snapshot: LTP Hits ₹4,093 with 0.4% Gain Amid Steady Pharma Rally and Elevated P/E

Mumbai, February 13, 2026 – Torrent Pharmaceuticals Ltd. (TORNTPHARM) edged up 0.4% to ₹4,093.60 on Thursday, amid a modest intra-day range (high ₹4,130, low ₹4,064.20), reflecting stability in the pharma sector despite broader market volatility. NSE data shows the stock's 1-year chart with an upward trend, supported by strong enterprise value at ₹1.40 Tr Cr and market cap of ₹1.38 Tr Cr, though its P/E ratio (TTM) at 64.86 remains elevated vs. industry average of 37.78. Dividend yield stands at 3.78%, attracting income-focused investors.

The snapshot underscores Torrent's position in the large-cap healthcare space, with consistent volume at ~3.83 lakh shares and value of ~₹1,570 Cr. Overall, the stock's performance highlights resilience in pharmaceuticals, driven by export growth and pipeline expansions, but caution on valuations persists.

Torrent Pharma Key Metrics Snapshot

Here's the overview from NSE data as of latest close:

Key Spotlights:

• Modest Gain Amid Rally: LTP rose 0.4% to ₹4,093.60, with intra-day high at ₹4,130, signaling steady buying in pharma amid global demand.
• Valuation Premium: P/E at 64.86 vs. industry 37.78 suggests growth pricing, but may cap upside if earnings disappoint.
• Market Position: Large-cap with ₹1.38 Tr Cr market cap, offering stability—dividend yield of 3.78% appeals to long-term holders.
• Chart Trend: 1Y upward trajectory shows resilience, but recent flattish movement hints at consolidation.

Value hunters may eye TORNTPHARM (LTP ₹4,093.60) for its sector strength, but downside risks linger if FII selling continues. Watch Q4 earnings for turnaround. BSE/NSE data; levels as of latest close.